"10.1371_journal.pone.0141911","plos one","2015-12-02T00:00:00Z","Marius M Hoeper; Juergen Behr; Matthias Held; Ekkehard Grunig; C Dario Vizza; Anton Vonk-Noordegraaf; Tobias J Lange; Martin Claussen; Christian Grohé; Hans Klose; Karen M Olsson; Thomas Zelniker; Claus Neurohr; Oliver Distler; Hubert Wirtz; Christian Opitz; Doerte Huscher; David Pittrow; J Simon R Gibbs","Department of Respiratory Medicine and German Center of Lung Research (DZL), Hannover Medical School, Hannover, Germany; Department of Internal Medicine V, University of Munich, Munich, Germany; Department of Internal Medicine, Respiratory Medicine and Cardiology, Mission Medical Hospital, Würzburg, Germany; University Hospital Heidelberg, Heidelberg, Germany; Department of Cardiovascular and Respiratory Diseases, Sapienza, University of Rome, Rome, Italy; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine II, Division of Pneumology, University Medical Center Regensburg, Regensburg, Germany; LungenClinic, Grosshansdorf, Germany; Department of Respiratory Medicine, ELK Thorax Centre, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Center of Oncology, Department of Respiratory Medicine, Hamburg, Germany; Department of Cardiology, Angiology and Pneumology, University of Heidelberg, Heidelberg, Germany; Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland; Department of Respiratory Medicine, University of Leipzig, Leipzig, Germany; Department of Cardiology, DRK Kliniken Berlin Köpenick, Berlin, Germany; Department of Rheumatology and Clinical Immunology, Charité University Hospital, and Epidemiology unit, German Rheumatism Research Centre, Berlin, Germany; Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany; Department of Cardiology, National Heart & Lung Institute; Imperial College London, London, United Kingdom","Conceived and designed the experiments: MMH DH DP JSG. Performed the experiments: MMH JB MH EG CDV AVN TJL MC CG HK KMO TZ CN OD HW CO DH DP JSG. Analyzed the data: DH DP MMH. Wrote the paper: MMH JB MH EG CDV AVN TJL MC CG HK KMO TZ CN OD HW CO DH DP JSG.","MM Hoeper has received speaker fees and honoraria for consultations from Actelion, Bayer, GSK, and Pfizer. J Behr has received honoraria for lectures and/or consultancy from Actelion, Bayer, Boehringer, Gilead, GSK, InterMune, Lilly, MSD, Novartis, and Pfizer. M Held has received speaker fees and honoraria for consultations from Actelion, Bayer, Boehringer Ingelheim Pharma, Glaxo Smith Kline, Lilly, Janssen, Novartis, Pfizer, Nycomed, Roche and Servier. E Grunig has received honorariums for consultations and/or speaking at conferences from Actelion, Bayer, Gilead, GSK, Lilly, Milteney, Novartis, Pfizer and Rotex Medica and funding for clinical trials by Actelion, Bayer, GSK, Encysive, Lilly and Pfizer. Carmine Dario Vizza has received fees for serving as a speaker, consultant and an advisory board member, from the following companies: Actelion, Dompè, GSK, Italfarmaco, Lilly, Pfizer, United Therapeutics. A Vonk-Noordegraaf reports receiving lecture fees from Actelion, Bayer, GlaxoSmithKline, Lilly and Pfizer, industry advisory board from Actelion and Bayer and serving on steering committees for Actelion, Bayer, GlaxoSmithKline and Pfizer. TJ Lange has received speaker fees, honoraria for consultations and/or research, and educational grants from Actelion, AOP Orphan Pharmaceuticals, Bayer, GSK, Pfizer, and United Therapeutics. M Claussen has received speaker fees and/or honoraria for consultations from Actelion, Bayer and Pfizer. C Grohé has received speaker fees and honoraria for consultations from Actelion, Bayer, Gilead, GSK, Lilly and Pfizer. H Klose has received speaker fees and honoraria for consultations from Actelion, Bayer, GSK, Lilly, Novartis, Pfizer, United Therapeutics and research grants from Actelion. KM Olsson has received speaker fees from Actelion, Bayer and Lilly. T Zelniker has no conflict of interest. C Neurohr has no conflict of interest. O Distler has received speaker fees, honoraria for consultations and/or grant support from 4D Science, Actelion, Active Biotec, Bayer-Schering, Biogen, Biovitrium, BMS, Boehringer, EpiPharm, Ergonex, GSK, Inventiva, Medac, Novartis, Pfizer, Pharmacyclics, Roche/Genentech, Sanofi/Genzyme, Serodapharm, Sinoxa and United BioSource Corporation. H Wirtz has received speaker fees and honoraria for consultations from Bayer, Novartis, GSK, Boehringer Ingelheim Pharma. CF Opitz has no personal conflicts of interest. His institution received speaker fees or honoraria for consultations from Actelion, Bayer, GSK, Lilly, Novartis and Pfizer. D Huscher has received author honoraria from Actelion. D Pittrow has received speaker fees or honoraria for consultations from Actelion, AstraZeneca, Aspen, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Genzyme, Novartis, and Pfizer. JSR Gibbs has received speaker fees and honoraria for consultations from Actelion, Bayer, Gilead, GSK, Lilly, Novartis and Pfizer. These commercial affiliations do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","12","Marius M Hoeper","MMH",19,TRUE,4,19,3,19,TRUE,TRUE,FALSE,0,NA,FALSE
